Abstract
Enterovirus infection, particularly with Coxsackie B virus serotypes, has been associated with heart muscle disease by serological studies and the use of mouse models. A study in Scotland by Grist and Bell [1] provided comprehensive serological data correlating enterovirus infection with myocarditis. However, the association of these viruses with dilated cardiomyopathy was less well established and was based mainly on the observation of high titres of neutralising antibody in cases of sudden onset disease (see below); this led to the proposal that dilated cardiomyopathy is a progression from an enteroviral myocarditis, itself a sequela of a common, frequently trivial or subclinical, enteric infection [2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Grist NR, Bell EJ (1974) A six year study of Coxsackie virus B infections in heart disease. J Hyg 73: 165–172
Goodwin JF (1983) Myocarditis as a possible cause of cardiomyopathy. In: Just H, Schuster HP (eds) Myocarditis. Cardiomyopathy. Springer, Berlin Heidelberg New York, pp 7–11
Grist NR, Bell EJ (1978) Enteroviruses in human disease. In: Melnick JL (ed) Progress in medical virology. Karger, Basel, pp 114–157
Morgan-Capner P, Richardson PJ, McSorley C, Daly K, Pattison JR (1984) Virus investigations in heart muscle disease. Springer, Berlin Heidelberg New York, pp 95–115
Cambridge G, MacArthur CGC, Waterson AP, Goodwin JF, Oakley CM (1979) Antibodies to Coxsackie B viruses in primary congestive cardiomyopathy, Br Heart J 41: 13–23
EI-Hagrassy MMO, Banatvala JE, Coltart DJ (1980) Coxsackie B specific IgM responses in patients with cardiac and other disease. Lancet 2: 1160–1162
McCartney RA, Banatvala JE, Bell EJ (1986) Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections. J Med Virol 19: 205–212
Muir P, Nicholson F, Tilzey AJ et al. (1989) Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet I: 804–807
Woodruff JF (1980) Viral myocarditis: a review. Am J Pathol 101: 425–484
Huber SA, Lodge PA, Job LP (1984) The role of virus and immune mediated cardiocyte injury in Coxsackie B3 induced myocarditis In: Bolte HD (ed) Viral heart disease. Springer, Berlin Heidelberg New York, pp 64–73
Reyes MP, Ho KL, Smith FE, Lerner AM (1981) A mouse model of dilated type cardiomyopathy due to Coxsackie B3 virus. J Infect Dis 144: 232–236
Klump WM, Bergmann I, Muller BC, Ameis D, Kandolf R (1990) Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5’ uridine residues are regained during plus-strand RNA synthesis. J Virol 64: 1573–1583
Stalhandske PO, Lindberg M, Pettersson U (1984) Replicase gene of Coxsackievirus B3. J Virol 51: 742–746
Kaczmarek L, Calabretta B, Baserga R (1985) Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes. Proc Natl Acad Sci USA 82: 5375–5379
Bowles NE, Rose ML, Taylor P et al. (1989) End-stage dilated cardiomyopathy: persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80: 1128–1136
Bowles NE, Richardson PJ, Olsen EG, Archard LC (1986) Detection of Coxsackie-B-virusspecific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1: 1120–1123
Archard LC, Richardson PJ, Olsen EG, Dubowitz V, Sewry C, Bowles NE (1987) The role of Coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. Biochem Soc Symp 53: 51–62
Kandolf R, Amies D, Kirschner P et al. (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 84: 6272–6276
Rotbart HA, Abzug MJ, Murray RS, Murphy NL, Levin MJ (1988) Intracellular detection of sense and antisense enteroviral RNA by in situ hybridization; J Virol Methods 22: 295–301
Cunningham L, Bowles NE, Lane RI, Dubowitz V, Archard LC (1990) Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol 71: 1399–1402
Archard LC, Bowles NE, Cunningham L, Freeke CA, Olsen EGJ, Rose ML, Meany B, Why HJF, Richardson PJ (1991) Molecular probes for detection of persisting enterovirus infection of human hearts and their prognostic value. Eur Heart J 12 (Suppl D): 56–59
Andino R, Rieckhof GE, Baltimore D (1990) A functional ribonucleoprotein complex forms around the 5’ end of poliovirus RNA. Cell 63: 369–380
Oldstone MB (1989) Viral alteration of cell function. Sci Am 261: 42–48
Chatterjee NK, Nejman C (1988) Insulin mRNA content in pancreatic beta cells of Coxsackie virus B4-induced diabetic mice. Mol Cell Endocrinol 55: 193–202
Otto MJ, Fox MP, Fancher MJ, Kuhrt MF, Diana GC, McKinlay MA (1985) In vitro activity of WIN 51711: a new broad spectrum antipicornavirus drug. Antimircrob Agents Chemother 27: 883–886
Hirsch MS, Kaplan JC (1990) Antiviral agents. In: Fields BN (ed) Virology. Raven Press, New York, pp 90: 441–468
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cunningham, L., Richardson, P.J., Archard, L.C. (1993). Enteroviral Heart Muscle Disease: Current Molecular Studies and Future Research. In: Goodwin, J.F., Olsen, E.G.J. (eds) Cardiomyopathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77598-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-77598-7_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77600-7
Online ISBN: 978-3-642-77598-7
eBook Packages: Springer Book Archive